| Current Price | $10.30 | Mkt Cap | $301.2M |
|---|---|---|---|
| Open | $0.00 | P/E Ratio | 0.00 |
| Prev. Close | $10.30 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.00 - $0.00 | Volume | 552,143 |
| 52-Wk Range | $4.55 - $15.82 | Avg. Daily Vol. | 448,111 |
| Current Price | $10.30 | Mkt Cap | $301.2M |
|---|---|---|---|
| Open | $0.00 | P/E Ratio | 0.00 |
| Prev. Close | $10.30 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.00 - $0.00 | Volume | 552,143 |
| 52-Wk Range | $4.55 - $15.82 | Avg. Daily Vol. | 448,111 |
The best Bull and Bear pitches based on recency and number of recommendations.
With market expectations now at rock-bottom thanks to Friday's press release, I believe now is a good time to initiate a position in Celladon.
Read the most recent pitches from players about EIGR.
Recs
oscillation
(74.73)
Submitted: 5/28/2015 9:24:56 AM :
Start Price:
$32.40
NASDAQ:EIGR Score:
-123.93
nev
Recs
treasureoaks
(< 20)
Submitted: 4/22/2015 3:54:19 PM :
Start Price:
$203.85
NASDAQ:EIGR Score:
-151.93
Oversold.
Recs
Jimbyrnes1969
(< 20)
Submitted: 4/9/2015 1:25:22 PM :
Start Price:
$252.36
NASDAQ:EIGR Score:
-154.69
I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock 300% in the short term but the real value will be when the therapy hits the market.
Find the members with the highest scoring picks in EIGR.
GreenAB (30.00) Score: +154.94
The Score Leader is the player with the highest score across all their picks in EIGR.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| GreenAB | 30.00 | 3/20/2015 |
|
NS | $405.00 | -97.46% | +57.49% | +154.94 | 0 Comment | |
| IdahoInvestor | 29.95 | 8/17/2015 |
|
5Y | $15.75 | -34.60% | +58.43% | +93.03 | 0 Comment | |
| sikiliza | < 20 | 3/13/2020 |
|
5Y | $5.71 | +80.39% | +25.62% | +54.76 | 0 Comment | |
| drugtrader | 91.63 | 7/8/2020 |
|
5Y | $9.43 | +9.23% | +5.69% | +3.54 | 0 Comment | |
| Playa14 | < 20 | 1/16/2018 |
|
5Y | $8.48 | +21.48% | +18.80% | +2.67 | 0 Comment | |
| odocoileus | 60.71 | 9/10/2020 |
|
5Y | $10.48 | -1.72% | -1.28% | -0.44 | 0 Comment | |
| BigDreamer | 53.29 | 1/29/2018 |
|
3Y | $8.95 | +15.08% | +15.64% | -0.56 | 0 Comment | |
| drcor | 52.91 | 1/23/2018 |
|
3M | $8.90 | +15.73% | +16.67% | -0.94 | 0 Comment | |
| cruisin25 | 30.77 | 7/22/2020 |
|
3M | $10.25 | +0.49% | +1.50% | -1.01 | 0 Comment | |
| skyrocket29 | 64.46 | 1/16/2018 |
|
3M | $9.10 | +13.19% | +18.19% | -5.01 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
